ESTRO 35 2016 S95 ______________________________________________________________________________________________________ tracking) may mitigate the detrimental effects of motion, but requires reliable target motion monitoring. On a conventional linac, monitoring can be obtained by intrafraction kilovoltage monitoring (KIM) using continuous imaging of implanted fiducials with a standard gantry-mounted x-ray imager. However, KIM adds imaging dose, is incompatible with large couch rotation, and KIM images suffer from MV scatter onto the kV imager. This study investigates the use of external monitoring combined with sparse kV imaging during beam pauses to overcome KIM limitations.
Results: Figs. B-C compare the estimated INT(t) with and without model updates with the ground truth positions in intra-treatment kV images at one fraction. Table 1 shows the mean rmse for all fractions. ECM updates more than halved the SI rmse. Substantial internal cranial baseline drift up to 7 mm (mean 1.4 mm) occurred between the setup CBCT and the last field without a similar drift for the external surrogate, illustrating the need for intra-treatment ECM updates.
Conclusion: A correlation model between external surrogate motion and internal liver motion was established on a conventional linac from pre-treatment CBCT projections and used to estimate the intra-treatment target positions with and without model update. A simple update based on only one kV image per field substantially improved the localization accuracy. Real-time update of the model in all 3 motion directions is currently being developed and is expected to further improve the localization accuracy. The proposed method increases the versatility and reduces the imaging dose compared to current clinical KIM implementations.
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Motion management for partial arc VMAT treatments using intra-fractional 2D/3D registration H. Furtado 1 , Y. Seppenwoolde Purpose or Objective: Rotational radiotherapy IMRT (VMAT) has shown superior delivery efficiency with similar overall treatment plan quality compared to conventional IMRT. For lung treatments intra-fractional tumor motion is a major source of uncertainty in dose application leading to the enlargement of the PTV margins and possibly to increased dose delivery to OARs. Motion management by tracking the tumor using intra-fractional kV planar images has the potential to reduce position uncertainty and reduce the PTV margins. The challenge for rotational treatments is the poor tumor visibility at certain gantry angles. In this work we investigate the feasibility of delivering VMAT treatments using only partial arcs where the tumor is well visible and therefore tracking is feasible.
Material and Methods:
For our study we used the x-ray images acquired for CBCT reconstruction from five patients with NSCLC undergoing hypo-fractionated SBRT treatment (3 fractions of 13.5Gy prescribed to the 65% isodose). These xrays are comparable to kV fluoroscopy images acquired during a VMAT treatment. For each patient the evaluation consisted of two steps: first real-time 2D/3D registration was used to track the tumor location on each of the x-rays from the CBCT acquisition. We determined the gantry angle intervals for which it was possible to track the tumor by comparing registration results with manually annotated diaphragm motion. Second, VMAT plans were created for partial arcs chosen depending on the anatomy and tumor location (U=unlimited) for a PTV based on an ITV approach (ITV plus 4mm margin) and for the limited partial arcs where the tumor tracking worked (L=limited) for a PTV based on the midventilation CTV (5mm margin). The L partial arc plans were evaluated using the U plans as benchmark.
Results: For all cases is was possible to track the tumor in two arcs of about 90 degrees, typically with imaging around anterior-posterior (AP) or posterior-anterior (PA) projections. For patient 5 it was possible to track the tumor in all projections. In terms of plan quality, a target coverage of at least 99% to the 65% isodose was aimed for and could be achieved for all the U plans and for all the L plans except for one, where the available angle range led to an unfavorable dose distribution, which would be clinically not acceptable. Therefore this patient was omitted for further data evaluation. Table 1 summarizes the tracking angles and the DVH parameters. Figure 1 shows example tracking results and obtained plans for one patient.
